Dr Robin Jones is a medical oncologist with a specialist interest in bone and soft issue sarcomas. He has been principle investigator on numerous phase I, II and III trials.
He completed his medical training at Guy’s and St Thomas’ Hospital, and his oncology training at The Royal Marsden. His postgraduate research degree, with Professor Dowsett at the ICR, evaluated potential predictive and prognostic factors in breast cancer patients treated with neoadjuvant chemotherapy.
In January 2010 he was appointed Associate Professor and Director of the Sarcoma Program at the University of Washington and Fred Hutchinson Cancer Research Center in Seattle. He led a successful National Institutes of Health research programme and continued his translational and clinical trial-based research. The laboratory work with Dr Seth Pollack evaluated novel immunotherapeutic targets in bone and soft tissue sarcoma, and has led to a number of early-phase immunotherapeutic clinical trials in sarcoma.
Dr Jones returned to The Royal Marsden and ICR in December 2014, as Sarcoma Clinical Trials Team Leader and Consultant Medical Oncologist. He is continuing a number of trials of investigational agents in sarcoma as well as laboratory-based immunotherapy studies.
He is a member of the Sarcoma Alliance for Research through Collaboration (SARC) concept review committee, the American Joint Committee on Cancer (AJCC) soft tissue sarcoma staging panel and the American Society of Clinical Oncology (ASCO) Educational Committee, and was previously a member of the National Comprehensive Cancer Network (NCCN) Bone Tumour Panel.